{
    "name": "econazole topical",
    "comment": "Rx",
    "other_names": [
        "Ecoza"
    ],
    "classes": [
        "Antifungals",
        "Topicals"
    ],
    "source": "https://reference.medscape.com/drug/ecoza-econazole-topical-343487",
    "pregnancy": {
        "common": [
            "There are no available data on therapy use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.",
            "In animal reproduction studies, econazole nitrate did not cause malformation in mice, rabbits and/or rats at oral doses 80 or 40 times the human dermal dose"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Econazole nitrate did not cause malformation in mice, rabbits and/or rats; fetotoxic or embryotoxic effects were observed in oral fertility studies in rats receiving 10 to 40 times the human dermal dose; similar effects were observed in embryofetal and pre- and postnatal developmental studies in mice, rabbits and/or rats receiving oral doses 80 or 40 times human dermal dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There is no information available on presence of drug in human milk, effects of drug on breastfed infant, or on milk production after topical application of drug to women who are breastfeeding",
            "Not known whether product excreted in human milk; because many drugs excreted in human milk, exercise caution when drug administered to a nursing woman",
            "Consider developmental and health benefits of breastfeeding along with mother’s clinical need for therapy and any potential adverse effect on breastfed infant from drug or maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Foam dosage form is flammable, avoid heat, flame, and smoking during and immediately following application",
                "Foam contents under pressure; do not puncture and/or incinerate the containers",
                "Do not expose foam containers to heat and/or store at temperatures above 120°F (49°C) even when empty",
                "Do not store in direct sunlight"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "warfarin",
            "description": {
                "common": "econazole topical will increase the level or effect of warfarin by  anticoagulation. Use Caution/Monitor. Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase systemic absorption; monitor International Normalized Ratio (INR) and/or prothrombin time, especially for patients who apply to large body surface areas, in the genital area, or under occlusion"
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Erythema",
            "percent": "3"
        },
        {
            "name": "Burning and stinging sensations",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Application site reaction",
            "percent": null
        }
    ]
}